Cuba Begins HIV Vaccine Phase One Trials

A new vaccine from Cuba aimed at reducing the viral load of patients with the Human Immunodeficiency Virus (HIV) is beginning phase one of clinical trials. The vaccine is believed to improve the quality of life of HIV patients.

Yayri Caridad Prieto Correa, a researcher at Havana’s Center for Genetic Engineering and Biotechnology (CIGB) told the Cuban News Agency that the results from trials with the first nine patients did not display any adverse effects or toxicity. This is the main objective of phase one testing.

 After pre-clinical testing in laboratory animals and then in trials with the small group of patients, it has demonstrated the immune response of the organism is enhanced with the use of TERAVAC-VIH.

The researcher has stated this is a multi-year project and will take time. The project will include more tests with a greater number of seropositives whereby large-scale and comprehensive efficacy will be determined.

What is important, she stressed, is that the country’s scientific research institutions, and especially the CIGB, should continue the search for vaccine candidates against HIV as a top priority, although prevention is still the main method of prevention against infection.

Advertisement. Scroll to continue reading.

The target is to replace the current tripartite therapy, combining several methods that prevent the HIV infection, highly effective because the retroviral inhibitors block the spread of the virus. However, these inhibitors can cause collateral damage and create the necessity to suspend treatment.

The proposal was presented by Prieto Correa and the researchers at the first Congress BioProcess 2017, which took place in Camaguey.

Although the vaccine shows signs of efficacy, she clarified that it does not cure the disease.

 Its administration is carried out simultaneously through the mucosal route with the use of spray and intramuscular vaccination. Preliminarily testing has demonstrated that it diminishes the viral load in the CD8 cells.

Mother-to-child transmission was first eliminated in Cuba 31 years ago. Cuba is the first country globally to eliminate the transmission of HIV and Syphilis between mother and child. Cuba was recognized as a leader in HIV prevention by the World Health Organization (WHO). Margaret Chan, director general of WHO, said it was “one of the greatest public health achievements possible” and an important step towards an AIDs-free generation.

Advertisement. Scroll to continue reading.

News sourced from: ACN

Share
Published by
Zoe Veraz

Recent Posts

Cuba Joins the BRICS New Development Bank

In a move with both economic and geopolitical significance, Cuba has officially joined the New…

2 weeks ago

Cuba’s International Tourist Arrivals—June 2025

Cuba’s tourism sector, long a vital part of the island’s economy, is experiencing mixed fortunes…

2 weeks ago

Cuba Amplifies Voice of the Global South at BRICS 2025 in Brazil

Cuba took center stage at the 17th BRICS 2025 in Rio de Janeiro this weekend,…

1 month ago

FIHAV 2025 Set for this November

Cuba has confirmed the 41st edition of the Havana International Fair (FIHAV 2025) will take…

1 month ago

WestJet CEO Meets with Cuban President Amid Hopes for Expansion of Passenger Flights to Havana

WestJet CEO Alexis von Hoensbroech met Wednesday with Cuban President Miguel Díaz-Canel in Havana, a high-level meeting…

2 months ago

Cuba Expands Solar Parks as Energy Deficits Persist

Cuba is ramping up efforts to address energy shortages through the expansion of photovoltaic solar…

2 months ago